AEON Biopharma, Inc.
AEON
$0.24
$0.001.19%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -54.62M | -60.11M | -39.22M | -3.00K | -1.64M |
| Total Depreciation and Amortization | 78.00K | 78.00K | 78.00K | 81.00K | 87.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 40.73M | 47.81M | 28.78M | -10.75M | -9.47M |
| Change in Net Operating Assets | 169.00K | 189.00K | -6.94M | -2.55M | -2.56M |
| Cash from Operations | -13.64M | -12.04M | -17.31M | -13.22M | -13.58M |
| Capital Expenditure | 0.00 | 0.00 | -4.00K | -4.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -4.00K | -4.00K | -4.00K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.64M | 1.83M | 18.51M | 18.61M | 18.58M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.00M | 6.00M | 1.79M | -- | -- |
| Cash from Financing | 8.63M | 7.83M | 20.31M | 18.61M | 18.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.01M | -4.20M | 2.99M | 5.39M | 5.00M |